|
|
|
|
|
|
Sponsors and Collaborators: |
Medtronic Cardiac Rhythm Disease Management Medtronic |
Information provided by: | Medtronic Cardiac Rhythm Disease Management |
ClinicalTrials.gov Identifier: | NCT00291564 |
The purpose of this study is to gather information on how doctors program particular settings on cardiac resynchronization therapy implantable cardiac defibrillators (CRT-Ds), to analyze how these settings affect the amount of cardiac resynchronization therapy (CRT) patients receive and to evaluate the therapy approach for converting abnormally fast heartbeats into normal heartbeats. There are no experimental devices or procedures involved in this study.
Condition | Intervention |
Heart Failure |
Device: Cardiac Resynchronization Therapy Device |
MedlinePlus related topics: | Heart Failure |
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | Ensure Cardiac Resynchronization Therapy Study |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Show 32 Study Locations |
Medtronic Cardiac Rhythm Disease Management |
Medtronic |
Principal Investigator: | David Thompson, MD | Tennessee Cardiovascular Research Institute |
Study ID Numbers: | 239 |
First Received: | February 10, 2006 |
Last Updated: | December 17, 2007 |
ClinicalTrials.gov Identifier: | NCT00291564 |
Health Authority: | United States: Institutional Review Board |
|
|
|